MAIA Biotechnology Inc.

Stock Chart, Company Information, and Scan Results

$1.20(as of Dec 5, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

MAIA Biotechnology Inc. Company Information, Fundamentals, and Technical Indicators

Stock Price$1.20
Ticker SymbolMAIA
ExchangeNyse Mkt
SectorHealthcare
IndustryBiotechnology
Employees13
CountyUSA
Market Cap$44.4M
EBIDTAUnknown
10-Day Moving Average1.10
P/E Ratio-1.78
20-Day Moving Average1.07
Forward P/E Ratio0.00
50-Day Moving Average1.30
Earnings per Share-0.74
200-Day Moving Average1.61
Profit Margin-Infinity%
RSI53.74
Shares Outstanding37.0M
ATR0.12
52-Week High2.74
Volume241,776
52-Week Low0.87
Most Recent Support Level1.07
Book Value0.0M
Most Recent Resistance Level1.25
P/B Ratio956.14
Upper Keltner1.33
P/S RatioInfinity
Lower Keltner0.80
Debt-to-Equity Ratio1.33
Next Earnings Date03/23/2026
Cash Surplus0.9M
Next Ex-Dividend DateUnknown

MAIA Biotechnology, Inc., together with its subsidiaries, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer. Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. The company was incorporated in 2018 and is headquartered in Chicago, Illinois.

MAIA Biotechnology Inc. In Our Stock Scanner

As of Dec 08, 2025
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Hammer CandleScan Type: Candlestick Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.